Ghang B, Park J, Lee JS, Lim JS, et al. Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy. Kidney Int 2024 Nov 15:S0085-2538(24)00789-0. doi: 10.1016/j.kint.2024.
PMID: 39551133